ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

NCI Hires Harold Freeman To Direct New Center For Study Of Health Disparities.

June 16, 2000

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976

NIH Funding Strategies, UICC Fellowships

December 4, 1992

WETA Relents Will Air Documentary

April 10, 1987

ACS Board Tables Proposal For Accepting State, Local Funds

December 3, 1993